The largest database of trusted experimental protocols

Sphygmomanometer

Manufactured by Hill-Rom
Sourced in United States

The Sphygmomanometer is a medical device used to measure blood pressure. It consists of an inflatable cuff that is wrapped around the patient's arm and a gauge that displays the blood pressure reading.

Automatically generated - may contain errors

Lab products found in correlation

13 protocols using sphygmomanometer

1

Measuring Blood Pressure and BMI for T2D

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood pressure was measured two times with a Welch Allyn sphygmomanometer (Skaneateles Falls, NY, USA) after at least 5 min of rest (measured in a supine position). Body mass index (BMI) was calculated by dividing weight in kilograms by height in meters squared. Height and weight were measured while standing and without shoes. T2D treatment with respect to glucose control was classified according to the traditional treatment steps in nationwide guidelines and consisted of lifestyle interventions, oral blood-glucose-lowering drugs (OBGLD) (mainly metformin and sulfonylurea, but not dipeptidyl peptidase-4 (DPP4) inhibitors, glucagon-like peptide 1 (GLP1) agonists, and sodium–glucose cotransporter 2 (SGLT2) inhibitors) and insulin (both short-acting and prolonged-acting human insulin preparations). Lifestyle interventions include the advice not to smoke, getting enough physical exercise, weight loss if BMI exceeds 25, and dietician advice in case of insufficient weight loss.
+ Open protocol
+ Expand
2

Blood Pressure and ECG Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The participants abstained from strenuous physical activity for 24 h prior to testing. The participants abstained from caffeinated or stimulant beverages for 36 h and from alcohol for 72 h before BP and electrocardiogram (ECG) recording [23 (link)]. ECGs were obtained from patients who had fasted for 12 h overnight. Recordings were made in the morning period. After 3 min of rest, the BP was measured with a Welch Allyn sphygmomanometer. The participants were then instructed to stand in the supine position and to breathe normally [24 (link)]. An ECG model 26T-LTS with a 5-electrode configuration was used for data acquisition (ADinstruments®, Bella Vista, NSW, Australia). The ECG was recorded for 10 min, and the data were exported and analyzed blindly [12 (link),25 (link)].
+ Open protocol
+ Expand
3

Macrovascular Complications and Prx4 Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical data were obtained from medical records at the time of inclusion in the ZODIAC study, which consisted of a complete medical history including macrovascular complications, medication use, diabetes duration and smoking history. Patients were considered to have macrovascular complications when they had a history of angina pectoris, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, stroke or transient ischemic attack. Laboratory and physical assessment data, such as glycated hemoglobin (HbA1c), non-fasting lipid profile, serum creatinine, albuminuria (albumin-to-creatinine ratio), body mass index (BMI), and blood pressure were collected annually. Blood pressure was measured twice with a Welch Allyn Sphygmomanometer in the supine position after at least five minutes of rest. For each visit the mean blood pressure of two recordings was calculated.
Of the 1689 included patients, 1374 samples were eligible for further analyses to measure Prx4. Complete information on Prx4 and potential confounders in this patient group was available for 1161 patients.
+ Open protocol
+ Expand
4

Comprehensive Assessment of Proximal Hip Dysfunction

Check if the same lab product or an alternative is used in the 5 most similar protocols
RTP criteria have been defined26 (link) and include symmetrical hip flexion/internal rotation range of motion and
pain-free squeeze test in 45° and 0° of hip flexion,9 (link) pubic stress test,18 and linear and multidirectional running.26 (link) The squeeze tests were recorded using a sphygmomanometer (Welch Allyn),
preinflated to 20 mm Hg, with a maximum value and a value at first onset of pain
recorded.9 (link),18 Self-reported disability and function were assessed using
the HAGOS (0-100, with 100 indicating nil problems),49 (link) and the level of sporting activity was assessed with the Marx activity scale22 (link) (0-16, with higher scores indicating increased frequency of high-demand
sporting activity).
+ Open protocol
+ Expand
5

Cardiorespiratory Fitness Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primary outcome of the study will be cardiorespiratory fitness ( V˙ O2 peak: mL/kg/min) measured by a maximal cardiopulmonary-exercise test (CPET) on an ergocycle (Ergoline 800S, Bitz, Germany). The protocol will be individualised and will include a 3 min warm up at 20 W, followed by an increase in workload from 10 to 20 W/min (depending on the participant’s fitness level) until exhaustion, while maintaining cadence >60 rpm. Electrocardiogram (Marquette, case 12, St. Louis, MI, USA) and oxygen saturation will be continuously monitored, whereas the rating of perceived exertion (Borg Scale, 6–20) and manual blood pressure (sphygmomanometer: Welch Allyn Inc., Skaneateles Falls, NY, USA) will be measured every 2 min during the test. Participants will be encouraged during the test. Minute ventilation ( V˙ E: L/min), oxygen uptake ( V˙ O2: mL/min) and carbon dioxide production ( V˙ CO2: mL/min) will be continuously measured at rest as well as during exercise and recovery using a metabolic system (Cosmed Quark, Rome, Italy). Gas exchange will be collected on a breath-by-breath basis and expressed with a 15 s time averaging for analysis. The highest V˙ O2 value during the exercise period will be considered as the V˙ O2 peak.
+ Open protocol
+ Expand
6

Questionnaire-Based Cardiometabolic Risk Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
A questionnaire was administered to participants in order to retrieve information regarding their age, socio-demographic data, medical history (menopause history, previous diseases; including history of atraumatic bone fracture, time of illness and use of medication), lifestyle (nutritional counseling, levels of physical activity and smoking). Duration of type 2 diabetes mellitus and arterial hypertension was recorded based on the date of diagnosis self-reported by patient.
Body weight was measured to the nearest 0.1 kg (Inbody 370). Ht was measured to the nearest 0.5 cm using a stadiometer (anthropometric balance Caumaq mechanical capacity 300 kg) and BMI (kg/m2) was calculated as the wt divided by the h2 (wt/h2).
Blood pressure was measured through the Welch Allyn sphygmomanometer with appropriate arm circumference cuff following the recommendations of the 2013 ESH/ESC Guidelines for the management of arterial hypertension.11 (link)
+ Open protocol
+ Expand
7

Anthropometric and Cardiovascular Assessment in Children

Check if the same lab product or an alternative is used in the 5 most similar protocols
A brief survey was conducted on sociodemographic characteristics and family history for data collection. The survey was designed by a pediatric physician and a nutritionist. Anthropometric measurements were taken in the presence of the parents and/or child´s guardian, and American Union criteria were used. Weight was measured using a scale and SECA® stadiometer while barefoot and wearing light clothing, and abdominal circumference was measured with an inextensible tape measure. Waist circumference was measured at the lower edge of the last rib and the upper edge of the iliac crest; the standard error for weight was less than 0.02 kg, and that for circumference was less than 0.01 cm, as indicated by the American Diabetes Association. Body mass index (BMI) was calculated for nutritional status using the Z-score with its respective cutoff points according to the WHO [12 (link)]. Trained personnel measured blood pressure with a sphygmomanometer (Welch Allyn, Ciudad de Mexico, Mexico) and stethoscope (3MTMLittmann, Ciudad de Mexico, Mexico).
+ Open protocol
+ Expand
8

Comprehensive Cardiovascular Risk Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Baseline data consisting of a full medical history were collected in 1998 and 2001. Patients were considered to have macrovascular complications when they had a previous history of angina pectoris, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, stroke, or transient ischaemic attack. Physical and laboratory assessment data, such as blood pressure, body mass index, lipid profile, creatinine levels, HbA1c and urinary albumin-creatinine ratio, were collected annually. Blood pressure was measured twice with a Welch Allyn Sphygmomanometer in supine position after at least five minutes of rest. The mean blood pressure of two recordings was calculated for each visit.
+ Open protocol
+ Expand
9

Blood Pressure Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
SBP and DBP were measured with a sphygmomanometer and blood pressure cuff (Welch Allyn Inc., Skaneateles, NY). Participants currently on blood pressure medication were asked to take their medication after blood pressure was measured on that day.
+ Open protocol
+ Expand
10

Ankle-Brachial Index Assessment for PAD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients were asked to rest in a supine position for 10 min. Afterwards, the systolic blood pressure (SBP) was measured in the brachial artery for each arm, using a sphygmomanometer (WelchAllyn) and an 8-mHz Doppler device (Huntleigh 500 D, Huntleigh Technology). The cuff was then placed in the distal calf and the Doppler was used to determine the SBP of both posterior tibial and dorsalis pedis arteries of each lower limb. The ABI for each leg was calculated by dividing the higher of the posterior tibial or dorsalis pedis pressure by the higher of the right or left arm SBP. According to the recommendations of the American Heart Association PAD was defined as having an ABI ≤ 0.9 in either leg, between 0.91 and 1.40 was considered normal, and when >1.4 was classified as suggestive of calcified non-compressible arteries. 3 The lower of the two ABI values obtained was used for the diagnosis of PAD. All sphygmomanometers were calibrated for the study and the ABI test was performed by trained health professionals.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!